Cargando…

Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy

BACKGROUND: Nanocarriers could deliver significantly higher amounts of antigen to antigen-presenting cells (APCs), which have great potential to stimulate humoral and cellular response in cancer immunotherapy. Thereafter, silica solid nanosphere (SiO(2)) was prepared, and a model antigen (ovalbumin,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Ying, Gao, Jing, Pei, Mengyue, Wang, Xiaoli, Zhang, Chuangnian, Du, Yingjie, Jiang, Yanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184137/ https://www.ncbi.nlm.nih.gov/pubmed/32368049 http://dx.doi.org/10.2147/IJN.S242463

Ejemplares similares

A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017)

In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)

A Magnetic Nanovaccine Enhances Cancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2019)

Artificially cloaked viral nanovaccine for cancer immunotherapy
por: Fusciello, Manlio, et al.
Publicado: (2019)

CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen, Wenqiang, et al.
Publicado: (2021)

Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
por: Fang, Xingliang, et al.
Publicado: (2022)

Research progress of nanovaccine in anti-tumor immunotherapy
por: Yao, Min, et al.
Publicado: (2023)

Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy
por: Sui, Yang, et al.
Publicado: (2022)

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
por: Jiang, Xiaoyi, et al.
Publicado: (2022)

Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
por: Lu, Lantian, et al.
Publicado: (2021)

Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023)

Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
por: Cai, Ting, et al.
Publicado: (2021)

Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023)

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors
por: Matos, Ana I., et al.
Publicado: (2023)

Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
por: He, Ao, et al.
Publicado: (2023)

Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens
por: Higa, Leticia H., et al.
Publicado: (2016)

Engineering anti-cancer nanovaccine based on antigen cross-presentation
por: Warrier, Vaishnavi U., et al.
Publicado: (2019)

Characterization of the Biodistribution of a Silica Vesicle Nanovaccine Carrying a Rhipicephalus (Boophilus) microplus Protective Antigen With in vivo Live Animal Imaging
por: Mody, Karishma T., et al.
Publicado: (2021)

Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
Publicado: (2022)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Fabrication of Mesoporous Silica Shells on Solid Silica Spheres Using Anionic Surfactants and Their Potential Application in Controlling Drug Release
por: El-Toni, Ahmed Mohamed, et al.
Publicado: (2012)

Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022)

An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer
por: Zhang, Yunting, et al.
Publicado: (2023)

Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy
por: Zhao, Peiqi, et al.
Publicado: (2022)

Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy
por: Jiang, Mingxia, et al.
Publicado: (2021)

Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli
por: Liu, Yan, et al.
Publicado: (2023)

Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report
por: Shao, Jie, et al.
Publicado: (2022)

Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
por: Liu, Wen-Long, et al.
Publicado: (2019)

Bacterial outer membrane vesicle-based cancer nanovaccines
por: Gao, Xiaoyu, et al.
Publicado: (2022)

Maximum Incorporation of Soft Microgel at Interfaces of Water in Oil Emulsion Droplets Stabilized by Solid Silica Spheres
por: Stock, Sebastian, et al.
Publicado: (2022)

Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
por: Li, Bo, et al.
Publicado: (2016)

Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
por: Zhu, Guizhi, et al.
Publicado: (2017)

A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020)

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
por: Su, Ting, et al.
Publicado: (2022)

Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy
por: Makandar, Amina I., et al.
Publicado: (2022)

Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions
por: Li, Yueyi, et al.
Publicado: (2023)

Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect
por: Cheng, Furong, et al.
Publicado: (2023)

Probiotics formulation and cancer nanovaccines show synergistic effect in immunotherapy and prevention of colon cancer
por: Xu, Xiangxiang, et al.
Publicado: (2023)

A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine
por: Zhai, Yuewen, et al.
Publicado: (2021)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b87fiufc3i8cv7a2uroh7ge5ce